Quarterly CAPEX
$399.00 K
-$1.62 M-80.27%
September 30, 2024
Summary
- As of February 7, 2025, GLUE quarterly capital expenditures is $399.00 thousand, with the most recent change of -$1.62 million (-80.27%) on September 30, 2024.
- Over the past year, GLUE quarterly CAPEX has dropped by -$985.00 thousand (-71.17%).
- GLUE quarterly CAPEX is now -80.27% below its all-time high of $2.02 million, reached on June 30, 2024.
Performance
GLUE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$3.81 M
+$399.00 K+11.71%
September 30, 2024
Summary
- As of February 7, 2025, GLUE TTM capital expenditures is $3.81 million, with the most recent change of +$399.00 thousand (+11.71%) on September 30, 2024.
- Over the past year, GLUE TTM CAPEX has increased by +$2.42 million (+174.93%).
- GLUE TTM CAPEX is now at all-time high.
Performance
GLUE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
GLUE CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -71.2% | +174.9% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
GLUE CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -80.3% | at low | at high | +174.9% | ||
5 y | 5-year | -80.3% | at low | at high | +174.9% | ||
alltime | all time | -80.3% | at low | at high | +174.9% |
Monte Rosa Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $399.00 K(-80.3%) | $3.81 M(+11.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2024 | - | $2.02 M(+46.1%) | $3.41 M(+146.1%) |
Mar 2024 | - | $1.38 M | $1.38 M |
FAQ
- What is Monte Rosa Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly CAPEX year-on-year change?
- What is Monte Rosa Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics TTM CAPEX year-on-year change?
What is Monte Rosa Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of GLUE is $399.00 K
What is the all time high quarterly CAPEX for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly capital expenditures is $2.02 M
What is Monte Rosa Therapeutics quarterly CAPEX year-on-year change?
Over the past year, GLUE quarterly capital expenditures has changed by -$985.00 K (-71.17%)
What is Monte Rosa Therapeutics TTM capital expenditures?
The current TTM CAPEX of GLUE is $3.81 M
What is the all time high TTM CAPEX for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high TTM capital expenditures is $3.81 M
What is Monte Rosa Therapeutics TTM CAPEX year-on-year change?
Over the past year, GLUE TTM capital expenditures has changed by +$2.42 M (+174.93%)